Product NDC: | 59630-801 |
Proprietary Name: | Twinject |
Non Proprietary Name: | Epinephrine |
Active Ingredient(s): | 1 mg/mL & nbsp; Epinephrine |
Administration Route(s): | INTRAMUSCULAR; SUBCUTANEOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 59630-801 |
Labeler Name: | Shionogi Pharma, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020800 |
Marketing Category: | NDA |
Start Marketing Date: | 20030530 |
Package NDC: | 59630-801-01 |
Package Description: | 1 SYRINGE in 1 CARTON (59630-801-01) > .15 mL in 1 SYRINGE |
NDC Code | 59630-801-01 |
Proprietary Name | Twinject |
Package Description | 1 SYRINGE in 1 CARTON (59630-801-01) > .15 mL in 1 SYRINGE |
Product NDC | 59630-801 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Epinephrine |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR; SUBCUTANEOUS |
Start Marketing Date | 20030530 |
Marketing Category Name | NDA |
Labeler Name | Shionogi Pharma, Inc. |
Substance Name | EPINEPHRINE |
Strength Number | 1 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [Chemical/Ingredient] |